Smart Money Is Betting Big In MRNA Options
Portfolio Pulse from Benzinga Insights
Smart money investors have shown a significant interest in Moderna's (NASDAQ:MRNA) options, with a balanced mix of bullish and bearish sentiments. Analysis of 12 trades reveals an equal distribution of bullish and bearish expectations among investors. The trades consist of 8 puts and 4 calls, indicating a price target range for Moderna between $50.0 and $120.0. The largest trades observed include both bullish and bearish positions, with notable activity in calls and puts. Moderna, a commercial-stage biotech company, is currently trading at $110.56, with an upcoming earnings announcement in 2 days.
April 30, 2024 | 5:16 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Moderna's options trading shows a balanced mix of bullish and bearish sentiments among investors, with a price target range between $50 and $120. The stock is currently trading at $110.56, with an upcoming earnings announcement.
The balanced mix of bullish and bearish sentiments in Moderna's options trading, combined with the upcoming earnings announcement, suggests a neutral short-term impact on the stock price. The significant interest in options trading, however, indicates high investor attention which could lead to increased volatility around the earnings release.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100